PosterSessionOnline

13th International Conference on Malignant Lymphoma

17-20 June 2015 Lugano

About us


Discussion forum - 13th International Conference on Malignant Lymphoma Topic - CLL If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER

Thread / Poster	Author	Replies	Last reply

Chronic lymphocytic leukaemia treatment and outcome in the UKs population-based Haematological Malignancy Research Network	Russell Patmore	1	6/3/2015 3:53:00 PM


Response to rituximab in B-CLL patients is adversely impacted by frequency of IL-10 competent B-CLL cells and FCGR3A polymorphism. A study of FCGCLL/MW and GOELAMS groups.	Anne-laure Gagez	1	6/3/2015 12:59:00 PM


Chronic Lymphocytic Leukemia B-cells are rescued from apoptosis by extracellular vesicles from bone marrow mesenchymal stromal cells	Emerence Crompot	1	5/29/2015 3:07:00 PM


Prognostic significance of TET and IDH mRNA expression in chronic lymphocytic leukemia	Michal Van Damme	1	5/28/2015 10:49:00 AM


Results of a Phase II randomizing intensified rituximab pre-phase followed by standard FCR vs standard FCR in previously untreated patients with Active B-CLL.	Stephane Lepretre	1	5/27/2015 12:31:00 PM


A Randomised Study of F(C)R in Fit, Elderly Patients with Chronic Lymphocytic Leukaemia (CLL) shows high response rates and a dose intensity effect	Stephen Mulligan	1	5/26/2015 2:21:00 PM


Most viewed poster for this congress

Poster: 9
Visits: 649
Title: Ibrutinib in combination with Rituximab for Relapsed Mantle Cell Lymphoma: An Update from a Phase II Clinical Trial
Authors: Michael Wang ,
Centre: The University of Texas MD Anderson Cancer Center


Poster most viewed in this topic

Poster: 169
Visits: 178
Title: Chronic Lymphocytic Leukemia B-cells are rescued from apoptosis by extracellular vesicles from bone marrow mesenchymal stromal cells
Authors: Emerence Crompot ,
Centre: LTCC

About us

Terms and Conditions

Special Access

Commercial Web Access